BiF-4 Insights – Deborah Brooks – Michael J. Fox Foundation

We want to de-risk ideas and help move them towards being taken into clinical trials.

We sometimes add money to company investments in order to make Phase 1 trials more robust than originally planned:

  • $4 million VC-funded trial, we incremented by $750k to fund neuro-imaging and extra doctor visit
    • In order to get more data out of the trial

We are almost filling the role of an early stage investor (in some cases).

Giving foundation money to drug companies must be a challenge for people giving money to the foundation to take, but we are pushing the envelope in order to do whatever we can to accelerate the finding of a cure.

For more information on the talk, go here.

Posted in

Braden Kelley

Braden Kelley is a Design Thinking, Innovation and Transformation Consultant, a popular innovation speaker and workshop leader, and helps companies use Human-Centered Change™ to beat the 70% change failure rate. He is the author of Charting Change from Palgrave Macmillan and Stoking Your Innovation Bonfire from John Wiley & Sons. Braden has been advising companies since 1996, while living and working in England, Germany, and the United States. Braden earned his MBA from top-rated London Business School. Follow him on Twitter and Linkedin.

NEVER MISS ANOTHER NEWSLETTER!

Categories

LATEST BLOGS

Carbon neutrality: what is it, how to achieve it and why you should care

By Hubert Day | June 22, 2022

When sustainability is on the agenda, you’re likely to hear many terms mentioned that you may or may not be…

Read More

Is remote working more eco-friendly than commuting?

By Hubert Day | May 31, 2022

Photo by NordWood Themes on Unsplash Working remotely became a part of everyday life for many people all over the…

Read More

Leave a Comment